P
Primary Clinical Research | Papillion, NE
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Maridebart Cafraglutide
MET097
PF-08653944
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
The purpose of this clinical study is to learn about the safety and effects of the study medicine to help adults with obesity or overweight and type...
Active, not recruiting
Overweight and/or Obesity
Overweight
Drug: PF-08653944
Other: Placebo
This study investigates the efficacy and safety of once weekly injectable MET097 in adult participants with obesity or overweight with weight-related...
Active, not recruiting
Obesity and Overweight
Drug: Placebo
Drug: MET097
The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of car...
Enrolling
Overweight
Atherosclerotic Cardiovascular Disease
Drug: Maridebart Cafraglutide
Drug: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems